Patient Monitoring

From the Clinical Practice Guidelines for the Management of Dyslipidemia by the Philippine Heart Association
This guideline starts below.

Patient Monitoring

The earliest time to repeat measurements of lipid profile should be within 6 weeks after initiation of therapy. This is a reasonable interval, especially in patients whose therapeutic goal is a 30% to 40% LDL reduction.

Less ideal monitoring options (e.g., total cholesterol only) may be used, provided that proper and adequate information and education is provided to help patients make an informed choice. Patients who choose total cholesterol for screening to initiate statin therapy may be given a fixed dose. Monitoring may be foregone for such patients. Total cholesterol may also be used for monitoring (to be conducted at the soonest after 6 weeks). Dose titration should aim for at least a 20% reduction of total cholesterol from baseline.